Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Prevalence of RhD status and clinical application of non-invasive prenatal determination of fetal RHD in maternal plasma: a 5 year experience in Cyprus.

Papasavva T, Martin P, Legler TJ, Liasides M, Anastasiou G, Christofides A, Christodoulou T, Demetriou S, Kerimis P, Kontos C, Leontiades G, Papapetrou D, Patroclos T, Phylaktou M, Zottis N, Karitzie E, Pavlou E, Kountouris P, Veldhuisen B, van der Schoot E, Kleanthous M.

BMC Res Notes. 2016 Apr 1;9:198. doi: 10.1186/s13104-016-2002-x.

2.

Noninvasive fetal blood grouping: present and future.

Daniels G, Finning K, Martin P.

Clin Lab Med. 2010 Jun;30(2):431-42. doi: 10.1016/j.cll.2010.02.006. Epub 2010 May 6.

PMID:
20513561
3.

Noninvasive prenatal diagnosis of fetal blood group phenotypes: current practice and future prospects.

Daniels G, Finning K, Martin P, Massey E.

Prenat Diagn. 2009 Feb;29(2):101-7. doi: 10.1002/pd.2172. Review.

PMID:
19085963
4.

The use of maternal plasma for prenatal RhD blood group genotyping.

Finning K, Martin P, Daniels G.

Methods Mol Biol. 2009;496:143-57. doi: 10.1007/978-1-59745-553-4_11. Review.

PMID:
18839110
5.

Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study.

Finning K, Martin P, Summers J, Massey E, Poole G, Daniels G.

BMJ. 2008 Apr 12;336(7648):816-8. doi: 10.1136/bmj.39518.463206.25. Epub 2008 Apr 3.

6.

Fetal blood group genotyping: present and future.

Daniels G, Finning K, Martin P, Summers J.

Ann N Y Acad Sci. 2006 Sep;1075:88-95.

PMID:
17108196
7.

Use of maternal plasma for noninvasive determination of fetal RhD status.

Harper TC, Finning KM, Martin P, Moise KJ Jr.

Am J Obstet Gynecol. 2004 Nov;191(5):1730-2.

PMID:
15547554

Supplemental Content

Loading ...
Support Center